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During mammalian development, sexual development is 
initiated  in  the  embryonic  gonad.  Male  gonadal  cells 
express  the  Sry  gene  (sex  determining  region  Y),  a  Y-
linked  gene  which  triggers  differentiation  of  the  testis. 
Steroidogenic  Leydig  cells,  within  the  testis,  produce 
testosterone, masculinizing non-gonadal tissues includ-
ing the sex ducts, the external genitalia and parts of the 
brain. The dominant role of hormones in masculinizing 
the brain was shown about 50 years ago by Alfred Jost. By 
treating female guinea pigs with testosterone prenatally, 
he  demonstrated  irreversible  male-type  behavioral 
changes. This early research suggested that XX and XY 
cells  were  equivalent  and  that  sexual  dimorphisms 
resulted  from  exposure  to  male  or  female  gonadal 
hormones [1]. However, the question of whether sexual 
dimorphism  is  completely  reliant  on  hormones  or 
whether there is also a genetic component has remained 
an area of interest. 
Heteromorphic  sex  chromosomes  make  cells  in  the 
male  and  female  intrinsically  different  in  terms  of  the 
dose  of  sex-linked  genes  (as  the  female  has  two  X 
chromosomes and the male has an X and a Y chromo-
some). This difference is balanced in part by inactivating 
one X-chromosome in females, which equalizes X gene 
dosage between males and females. However, in mice and 
humans, many genes escape inactivation, increasing the 
gene dosage of these loci in XX cells [2]. Therefore, it is 
not inconceivable that intrinsic chromosomal differences 
affect the differentiation of XX and XY cells. Brain and 
nerve cells seem to be sensitive to this inherent difference 
in gene dosage. For example, in cultures of mouse mid-
brains,  where  the  effect  of  hormones  is  probably 
negligible, XY explants develop more dopamine neurons 
than do XX explants. Similarly, the density of vasopressin 
fibers correlates with the presence of the Y chromosome, 
and  not  with  phenotypic  sex  (female  or  male)  [3]. 
However, Sry expression has been reported in regions of 
the mouse brain, challenging the idea that differences in 
neuronal  tissue  are  controlled  by  chromosome  dosage 
effects [4].
Outside  of  the  nervous  system,  sexually  dimorphic 
characteristics  exist  that  precede  gonad  differentiation, 
and hence hormone production [1]. In several species, 
the  size  of  male  and  female  embryos  differ.  In  the 
marsupial,  differentiation  of  the  scrotum  and  pouch 
begin  before  the  gonad  forms  and  is  controlled  by  X-
chromosome  dosage.  These  examples  support  the  idea 
that sex chromosome differences affect male and female 
development. However, it has been challenging to study 
sexual differentiation free from the effects of hormones 
to  assess  broader  contributions  of  dosage  effects  on 
sexual dimorphisms. A recent study by Wijchers et al. [5] 
has succeeded in doing this.
Sexual dimorphism and sex chromosome 
complement
In a recent Developmental Cell paper, Wijchers et al. [5] 
used  the  ‘four  core  genotypes’  (FCG)  mouse  model  to 
separate the genetic versus hormone dependent effects on 
variable silencing of heterochromatin. This mouse model 
was originally designed to test the relative contri  bution of 
sex  chromosomes  and  phenotypic  sex  to  sexually 
dimorphic characteristics [6]. In this system, XX and XY- 
mice are phenotypic females (Y- denotes a deletion of Sry), 
although  they  have  different  sex  chromo  some 
compositions. Similarly, XY-Sry and XXSry are pheno  typic 
males  exposed  to  similar  levels  of  androgens,  although 
they have different sex chromosome compositions.
Wijchers  et  al.  [5]  show  that  in  a  mouse  model  for 
position  effect  variegation,  expression  of  a  transgene, 
human CD2 (hCD2), which has integrated into a hetero-
chromatic  region  and  undergoes  variable  silencing  in 
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© 2010 BioMed Central LtdT cells, is more strongly silenced in males (XY) than in 
females (XX). To determine whether the dimorphic gene 
silencing was caused by a genetic or phenotypic compo-
nent,  they  crossed  the  hCD2  transgene  onto  the  FCG 
mice.  They  found  that  XY-  females  and  XY-Sry  males 
exhibited  increased  transgene  silencing  compared  with 
XX females and XXSry males. Therefore, silencing did 
not  depend  on  whether  the  individual  was  male  or 
female, but was dependent on a repressive effect of the Y 
chromosome,  or  a  role  for  two  X  chromosomes  in 
increas  ing expression. To distinguish between these two 
possibilities, they used two additional mouse lines; XXY* 
males (where a Y* is attached to an X chromosome) and 
XO females (which carry only one X chromosome). They 
found that XO females had lower expression of the hCD2 
transgene than did XXY* males. Although this experiment 
is confounded by different hormone environments, the 
positive  effect  of  two  X  chromosomes  on  transgene 
expression seemed to be dominant over any repressive 
effect the Y chromosome might have.
Having  uncovered  a  sex-chromosome  effect  on  gene 
silencing, the authors [5] performed a genome wide study 
to identify endogenous autosomal genes sensitive to sex 
chromosome composition. Microarray analyses of gene 
expression  from  FCG  thymus  samples  identified  over 
2,000 affected genes, including an overlapping set of 369 
genes that were differentially expressed between pheno-
typic  males  of  different  sex  chromosome  constitutions 
(XXSry versus XY-Sry), and between phenotypic females 
of  different  sex  chromosome  constitutions  (XX  versus 
XY-), termed the ‘sex-chromosome-complement sensitive 
set’ (SCS). Because the hCD2 transgene is silenced by the 
heterochromatin protein HP1, Wijchers and co-workers 
[5]  tested  the  SCS  gene  set  for  sensitivity  to  HP1  and 
found that relative to the number of genes in the entire 
T-cell genome silenced by this factor (4%), the SCS gene 
set was enriched for HP1-silenced genes (12%). However, 
in  contrast  to  the  results  obtained  using  the  CD2 
transgene reporter, X-chromosome dosage was not the 
dominant force in silencing the SCS genes. Instead, they 
found that XX females in fact exhibited more silencing 
than  XY-  females.  Here,  it  seemed  that  either  the 
increased X dosage was repressive, or the Y chromosome 
had a positive influence on expression of the SCS genes.
One  of  the  most  significant  differences  in  the 
expression levels of these genes was seen between XY-Sry 
males and XY-females. Here, the sex-chromosome dosage 
was  identical,  but  the  hormonal  environment  was 
different. When the comparison was repeated between 
XY-Sry males and XX females (recapitulating a normal 
chromosome  complement),  the  expression  differences 
were  reduced.  The  authors  [5]  conclude  that  the  SCS 
genes respond to multiple sex chromosome inputs, some 
of  which  are  distinct  from  the  effects  on  variegation. 
Overall Sry, and/or the hormonal environment it induces, 
tends  to  have  a  role  in  balancing  the  effects  of  sex 
chromosome dosage.
Finally, Wijchers et al. [5] investigated whether the SCS 
genes  constitute  a  subset  of  genes  that  normally  show 
expression differences between males and females. They 
identified 1,751 genes that were dimorphically expressed 
in the thymus of XY males and XX females, 10% of these 
(175  genes)  overlapped  the  SCS  gene  set,  whereas  an 
additional  23%  were  sensitive  in  only  one  sex.  The 
authors [5] conclude that a large portion (about 30%) of 
the  genes  that  are  normally  differentially  expressed  in 
male and female thymus can be attributed to effects of 
sex chromosome composition.
Future perspectives
Prior to this study, the effects of sex chromosomes on 
sexual  dimorphisms  were  mostly  limited  to  morpho-
logical  observations,  most  of  which  were  restricted  to 
differences  in  brain  structure  and  nervous  system 
differentiation. This study provides the first evidence that 
sex chromosomes can influence much broader, genome-
wide variations.
How might this work? The authors point out [5] that 
Xu et al. [7,8] recently used the same FCG mouse model 
to establish that increased expression of the two X-linked 
histone demethylases, Jarid1c and Utx, was dependent on 
having  two  copies  of  the  X  chromosome,  and  not  on 
sexual  differentiation.  Higher  expression  of  chromatin 
modifiers in one sex could directly affect the expression 
level  of  large  numbers  of  genes,  leading  to  sexually 
dimorphic  gene  expression  and  morphological  pheno-
types. In addition, it has been proposed for Drosophila 
that  a  large  heterochromatinized  region,  such  as  the 
inactive X, could act as a sink to sequester inactivating 
factors  reducing  access  for  other  silenced  regions  [9]. 
Along  these  lines,  in  Caenorhabditis  elegans,  dosage 
compensation proteins not only control X chromosome 
expression  levels,  but  also  act  in  other  complexes  that 
affect  other  regions  of  the  genome,  creating  inter-
dependent mechanisms [10].
In  humans,  males  and  females  exhibit  sexually  di-
morphic  changes  that  not  only  lead  to  morphological, 
physiological,  and  behavioral  differences,  but  also  to 
differences in disease susceptibility. The results presented 
here [5] suggest that the normal XX and XY karyotypes 
function  to  equalize  gene  expression  in  the  context  of 
their respective hormone environments. Disrupting the 
genetic component of this balance can lead to expression 
changes in genes such as the SCS set, which appear to be 
sensitized  to  differences  in  sex-chromosome  dosage. 
Human patients with sex chromosome aneuploidy, such 
as individuals with Turner’s (XO females) or Klinefelter’s 
(XXY  males)  syndromes,  can  have  gene  expression 
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ences can contribute to the distinct social and cognitive 
differences that distinguish these individuals from their 
‘normal’  female  and  male  counterparts  [3].  It  will  be 
interesting to see if the SCS genes identified by Wijchers 
et al. [5] are also dimorphically expressed in other cell 
types,  or  if  different  sets  of  genes  are  sensitive  to  sex 
chromosome dosage in other cell lineages.
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